https://european-biotechnology.net/wp-content/uploads/2024/10/lung-freepik-ai-20241008-1030x579-1.jpeg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-08 12:45:282024-10-08 12:45:28Vicore secures funding to accelerate drug development
https://european-biotechnology.net/wp-content/uploads/2024/10/Scotland-1030x618-1.jpg6181030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-03 07:25:302024-10-03 07:25:30Kurma closes new fund at €250m
https://european-biotechnology.net/wp-content/uploads/2024/09/LevinJM_Headshot_FINAL_20161028-1030x677-1.jpg6771030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-09-30 04:00:172024-09-30 04:00:17Long version of The BIOSECURE Act: The West’s Wake-Up Call to China’s Biotech Dominance
https://european-biotechnology.net/wp-content/uploads/2024/09/Alessio-Cantore-e1727256487625.jpg242430Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-09-25 09:33:552024-09-25 09:33:55Genespire raises US$52m in Series B round
